Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01307436
What this trial is testing

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Who this might be right for
Hepatitis A
Crucell Holland BV 327
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Not applicableUnknownNCT05486767
What this trial is testing

Screening of Liver Fibrosis in Adults Without Known Liver Disease

Who this might be right for
Liver Fibrosis
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica 1,000
Not applicableWithdrawnNCT00605800
What this trial is testing

Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00807300
What this trial is testing

Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 77
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07412236
What this trial is testing

A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.

Who this might be right for
Liver FibrosisLiver Fibrosis in Chronic Hepatitis B
Beijing Continent Pharmaceutical Co, Ltd. 1,208
Not applicableNot Yet RecruitingNCT06483711
What this trial is testing

Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Stanford University 50
Not applicableUnknownNCT04852211
What this trial is testing

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 212
Not applicableStudy completedNCT02383485
What this trial is testing

Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children

Who this might be right for
Overweight and ObesityNon-alcoholic Fatty Liver Disease
Augusta University 175
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Early research (Phase 1)Study completedNCT07069725
What this trial is testing

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.

Who this might be right for
Liver FibrosisHepatic Cirrhosis
AstraZeneca 8
Post-approval studies (Phase 4)UnknownNCT00939068
What this trial is testing

Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission

Who this might be right for
Chronic Hepatitis B, Gestation
Southeast University, China 180
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Testing effectiveness (Phase 2)Study completedNCT04971785
What this trial is testing

Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 457
Not applicableUnknownNCT01592578
What this trial is testing

The Research of the Evaluation of Clinical Procedures in Gastroesophageal Varices in Patients With Liver Cirrhosis

Who this might be right for
Gastroesophageal Varice
Shanghai Zhongshan Hospital 96
Not applicableUnknownNCT03268317
What this trial is testing

Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

Who this might be right for
Hepatitis C
Assiut University 100
Large-scale testing (Phase 3)UnknownNCT03794440
What this trial is testing

Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Innovent Biologics (Suzhou) Co. Ltd. 595
Post-approval studies (Phase 4)Study completedNCT01575574
What this trial is testing

Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis

Who this might be right for
Hepatocellular Carcinoma
Sara Varea 74
Testing effectiveness (Phase 2)Study completedNCT01258608
What this trial is testing

Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Human Genome Sciences Inc., a GSK Company 101
Next Page